Trinean is a Belgium-based startup that specializes in advancing micro-volume molecular spectroscopy with its premier analytical software and a standardized read-out platform. Established in 2006 as a spin-out from Ghent University and Imec Leuven, the company offers UV/VIS spectrometers designed for biomolecule quantification. Their DropSense™16 and DropSense™96 systems, capable of analyzing up to 16 and 96 samples respectively, employ microfluidic chips for standardized sample analysis (DropPlates™ and Slides). The startup's platform is further enhanced with a software toolbox aimed at improving data interpretation and lab automation.
The latest investment in Trinean was a €3.70M Venture Round closed on 27 April 2012. The investment was led by Capricorn Venture Partners, Vesalius Biocapital, Fidimec, Capital-E, and Baekeland Funds, indicating strong support and confidence from notable investors in the industry.
The company operates in the Analytics, Biotechnology, and Hardware industries, reflecting an innovative approach at the intersection of these sectors. With its robust technology and backing from prominent investors, Trinean is positioned for continued growth and influence in the molecular spectroscopy and biomolecule quantification space.
